Javascript DHTML Drop Down Menu Powered by Drop Down Menu
FullyInformed.com - Options and Stock Strategies For Income

SignUp For Updates 

  You are here:

Johnson & Johnson  
Trades By Years
View JNJ-2011 Trades
View JNJ-2010 Trades
View JNJ-2009 Trades
JNJ Articles

Rolling Put Options Strategy
Squeaker Trade
Defensive Investing
Stuck In A Range
The Value Of A Plan
More Put Selling

About The Company
Market Cap 164.8B
Revenue (FYR) $62.5B
EPS (TTM) $4.87
Shares Out. 2.7B
Book Value $20.85
Dividend Yield 3.60%
Div/Share $2.16
P/E 12.3x
Price/Sales (FYR) 2.6
P/Cash Flow (TTM) 10.0x

Johnson & Johnson is a profitable Major Drugs company JNJ is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. Johnson & Johnson has more than 250 operating companies.

The Company operates in three segments. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women's healthcare fields, as well as nutritional and over-the-counter pharmaceutical products.

The Pharmaceutical segment includes products in the therapeutic areas, such as anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology.

The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers. In July 2009, Johnson & Johnson completed the acquisition of Cougar Biotechnology, Inc. with approximately 95.9% interest in Cougar Biotechnology's outstanding common stock. 

 

 

 
Terms
Of Use
 
By using this site, you agree to be bound by its terms of use. The full terms of use can be read here. If you do not agree to the terms of use, do not access or use this site.
Nothing presented is financial advice, trading advice or recommendations. Everything presented is the author's ideas only. The author accepts no liability for its use including errors and omissions. You alone are solely responsible for your own investing and trading. There are considerable risks involved in implementing any investment strategies and losses can be large. Trade at your own risk.

 

 
  JOHNSON & JOHNSON  (JNJ) - 2011
ONGOING EVALUATION & TRADE  Bookmark and Share
The current strategy is selling naked puts near and at the money until I either accept assignment OR get assigned shares. Then I will turn to covered calls. Should the stock fall too low  making covered call selling impractical I will add to my stock position through selling naked puts to lower my overall cost.
ALL
PORTFOLIOS
INDEX
U.S. STOCKS
RETIREMENT PORTFOLIO
CANADIAN STOCKS

 
CURRENT U.S.
STOCK PORTFOLIO
INDEX

AT+T
CLOROX
COCA COLA
INTEL CORPORATION
JOHNSON & JOHNSON
KRAFT FOODS
MCDONALDS
MERCK & COMPANY
MICROSOFT
NUCOR CORPORATION
PEPSICO
SPYDER ETF
VISA
EXXON MOBIL
YUM! BRANDS

 
Should you find my strategy and ongoing evaluation of this trade of value I hope you will consider a tip for the time I spend detailing out this trade. I have set up a Paypal account for those who would like to donate. Thank you in advance. Remember, nothing on my site is financial advice. They are just my ideas and opinions. Investing is risky and losses can be large. Trade at your own risk. Read the terms of use

 

 

YEAR 1: 2009 - Trade Commenced Feb 26 2009
Goal for 2009: 8.5% (10 months)
Strategy: Sell Naked Puts Until Assigned
 
Capital In Use At End Of 2009 53,500.00
Income Earned in 2009 (10 months) 4276.00
Return On Capital in 2009 (5 months) 7.9%
   
YEAR 2: 2010
Goal for 2010: 10%
Strategy: Sell Naked Puts Until Assigned
 
Capital In Use At End Of 2010 81,000.00
Income Earned in 2010 7960.75
Return On Capital For 2010 9.8%
   
YEAR 3: 2011
Goal for 2011: 12%
Strategy: Sell Naked Puts Until Assigned
 
Capital Currently In Use 82295.50
Income Earned in 2011 4893.50
TOTAL INCOME EARNED TO DATE 17130.25
Total Of My Own Capital Required 65165.25
Number Of Shares if assigned 1400
Share Price Valuation
(Total Capital Required/Number of shares)
46.55

 

TRADE COMMENCED: Feb 26 2009
* ACTIVE TRADES ARE HIGHLIGHTED IN YELLOW

 

Dec 17 10 62.54 STO 2 NP JAN 2012 60.00 @ 4.60 7.6   9.50   12009.50 910.50 11921.75
Dec 31 10 61.85 BTC 2 NP JAN $65.00 @ 3.10 4.7   9.50     (629.50) 11292.25
Dec 31 10 61.85 STO 2 NP FEB $65.00 @ 3.55
COMMENTS: This is a roll from Jan to Feb to continue bringing in more premium. I would not roll out further, in case the stock should move higher which would decrease the premium in the Feb put and increase premiums should I roll further out in time.
5.4   9.50     700.50 11992.75
Dec 31 10 61.85 BTC 4 Naked Puts JAN $57.50 @ .08 0.13   12.00     (44.00) 11948.75
Dec 31 10 61.85 STO 4 Naked Puts FEB $60 @ .75 1.25   12.00     288.00 12236.75
END OF 2010 - EARNINGS - $7960.75 =  9.8%
Jan 21 11 62.90 BTC 2 NP JAN $62.50 @ .05     9.50     (19.50) 12217.25

Jan 24 2011: COMMENTS: What a great performer. Anyone who is buying JNJ for capital gain may wait a while, but I am enjoying the stock's sideways action. You can read my comments, strategy and the chart to Jan 24 2011 here.

Jan 24 11 62.35 STO 4 NP 19MAR11 $62.50 @ 1.65 4.8   12.00     648.00 12865.25
Feb 18 11 61.00 Expiry: BTC 2 NP FEB $65.00 @ $4.15
4 Naked Puts Feb $60 expired
(6.3%)   9.50     (839.50) 12025.75
Feb 22 11 60.90 STO 2 NP 16JUL11 $65.00 @ $4.95 7.6%   9.50     980.50 13006.25
Feb 28 11 61.30 BTC 4 NP 19MAR11 $62.50 @ 1.72
COMMENTS: With today's upturn I closed my Mar $62.50 naked puts. I then reduced the number of puts to 2 and moved to April $62.50 and held 2 back.
(2.7%)   12.00     (700.00) 12306.25
Mar 2 11 60.50 STO 2 NP 16APR11 $62.50 @ 2.65 4.2%   9.50     520.50 12826.75
Mar 16 11 57.70 STO 2 NP 16JUL11 $57.50 @ 2.87
COMMENTS: I have taken advantage of today's downturn to sell out to July, the other two naked puts but at $57.50 which covers the entire cost of the buy back of the Mar $62.50 and leaves me with a further profit.
5.0%   9.50     564.50 13391.25
Mar 18 11 58.60 BTC 3 NP 16APR11 $65.00 @ 6.50
I took advantage of today's upturn to buy back my Apr $65.00 puts. I then have rolled out two of them to Jan to reduce my overall cost on the puts.
(10%)   10.75     (1960.75) 11430.50
Mar 18 11 58.25 STO 2 NP 21JAN12 $65.00 @ 9.05 (Bought back on Nov 29 11 for $2.85) 13.9%   9.50   13009.50 1800.50 13231.00
Mar 18 2011: I received a lot of emails this week from concerned investors as JNJ pulled back. The recent downturn in Johnson and Johnson does not concern me. In fact it is an opportunity. Read here the importance of having a plan when investing in a stock, including Johnson and Johnson stock.
Apr 15 11 60.56 Expiry: Bought to close 2 Naked Puts April $62.50 @ 2.27     9.50     (463.50) 12,767.50
Apr 15 2011: Johnson and Johnson continues to stay in a narrow trading range. I bought and closed my April 62.50 puts and moved out to October 62.50. You can view my chart and read my latest comments on JNJ here.
Apr 15 11 60.56 STO 2 Naked Puts October $62.50 @ 4.15     9.50   12509.50 820.50 13,588.00
Jul 15 11 67.45 Expiry: 2 NP 16JUL11 65 expired
           2 NP 16JUL11 $57.50 expired
COMMENTS: Do you recall this trade? This trade started back on April 17 2010. Click here to read this article which discusses this trade at the $65 strike.
             
Sep 6 11 62.67 Sold 5 Naked Puts Oct $57.50 @ .80 1.39   13.25   28763.25 386.75 13974.75
Sep 22 11 61.25 Sold 3 Naked Puts Nov $57.50 at 1.37 2.3%   10.75   17260.75 400.25 14375.00
Oct 16 11 63.78 Expiry: 2 Oct $62.50 naked puts expired. 5 Oct $57.50 puts expired              
Oct 25 11 63.77 Sold 8 Naked Puts 19NOV11 $62.50 at .80 1.2%   17.00   50017.00 623.00 14998.00
Nov 21 11 62.90 Sold 4 Naked Puts 17DEC11 $60.00 @ .65 1.0%   12.00   24012.00 248.00 15246.00
Nov 25 11 61.20 Sold 4 Naked Puts 21JAN12 $57.50 @ .90     12.00   23012.00 348.00 15594.00
Nov 25 11 61.20 Sold 3 Naked Puts 19JAN13 $57.50 @ $5.25     10.75   17260.75 1564.25 17158.25
Nov 29 11 63.10 Bought to close 2 Naked Puts 21JAN12 $65 @ $2.85     9.50     (579.500 16578.75
Dec 5 11 62.90 Sold 10 Naked Puts 17DEC11 $60 @ .33 .50%   19.50   60019.50 310.50 16889.25
Dec 9 11 64.53 Bought to close 15 Naked Puts 17DEC11 $60 @ .03     25.75     (70.75) 16818.50
Dec 19 11 63.40 Sold 5 Naked Puts 18FEB12 $60.00 @ .65 1.0   13.25   30013.25 311.75 17130.25
Johnson & Johnson  
Trades By Years
View JNJ-2011 Trades
View JNJ-2010 Trades
View JNJ-2009 Trades
JNJ Articles

Rolling Put Options Strategy
Squeaker Trade
Defensive Investing
Stuck In A Range
The Value Of A Plan
More Put Selling

 

Disclaimer: There are considerable risks involved in all investment strategies. Trade at your own risk.
Stocks, options and investing are risky and can result in considerable losses. None of the strategies, stocks or information discussed or presented are financial advice, trading advice or recommendations. Fullyinformed.com is a private website. Everything presented and discussed are the author's ideas and opinions only.
By using this site, you agree to be bound by its terms of use. The full terms of use can be read here. If you do not agree to the terms of use, do not use this site. The author of fullyinformed.com assumes no liability for topics and ideas discussed, errors and omissions, ads and their content and external links. Any corporate insignia used are registered trademarks of their respective company or corporation and are being used for identification purposes only. All material copyrighted by FullyInformed.com. Reproduction in whole or in part prohibited. Copyright 2008

 |  site map  |  privacy policy  |  contact me  |  subscribe  |  exchange links  |  the author of fullyinformed  |